Amneal Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AMRX and other ETFs, options, and stocks.About AMRX
Amneal Pharmaceuticals, Inc. is a medicine company, which engages in the provision of pharmaceuticals. Its product portfolio includes generics, specialty, biosciences, and product catalog.
CEOChintu Patel
CEOChintu Patel
Employees7,850
Employees7,850
HeadquartersBridgewater, New Jersey
HeadquartersBridgewater, New Jersey
Founded2002
Founded2002
Employees7,850
Employees7,850
AMRX Key Statistics
Market cap2.09B
Market cap2.09B
Price-Earnings ratio-11.96
Price-Earnings ratio-11.96
Dividend yield—
Dividend yield—
Average volume2.12M
Average volume2.12M
High today$6.90
High today$6.90
Low today$5.81
Low today$5.81
Open price$6.25
Open price$6.25
Volume3.85M
Volume3.85M
52 Week high$6.90
52 Week high$6.90
52 Week low$1.74
52 Week low$1.74
AMRX News
Yahoo Finance 2h
Amneal Pharmaceuticals, Inc. Q1 2024 Earnings Call Transcript - Yahoo FinanceAmneal Pharmaceuticals, Inc. (NYSE:AMRX) Q1 2024 Earnings Call Transcript May 3, 2024 Amneal Pharmaceuticals, Inc. misses on earnings expectations. Reported EP...
Seeking Alpha 19h
Amneal stock climbs on Q1 report, opioid settlement updateShares of Amneal Pharmaceuticals (NASDAQ:AMRX) climbed 9% Friday after the drugmaker released a better-than-expected Q1 earnings report and said it had reached...
Benzinga 20h
Generic Drugmaker Amneal Announces Over $270M In US Opioid Lawsuit SettlementLoading... Loading... Friday, Amneal Pharmaceuticals Inc AMRX announced a significant agreement valued at over $270 million to settle claims related to its all...
More AMRX News
Yahoo Finance 1d
Amneal Reports First Quarter 2024 Financial Results - Yahoo Finance‒ Q1 2024 Net Revenue of $659 million; GAAP Net Loss of $92 million; Diluted Loss per Share of $0.30 ‒ ‒ Adjusted EBITDA of $152 million; Adjusted Diluted EPS...
